Literature DB >> 23467463

Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis.

Philipp Lutz1, Holger Strunk, Hans Heinz Schild, Tilman Sauerbruch.   

Abstract

A pleural effusion containing chylomicrons is termed chylothorax and results from leakage of lymph fluid into the pleural cavity. We report on the case of a 59-year-old woman with severe dyspnea due to a large chylothorax. She was known to have liver cirrhosis but no ascites. There was no history of trauma, cardiac function was normal and thorough diagnostic work-up did not reveal any signs of malignancy. In summary, no other etiology of the chylothorax than portal hypertension could be found. Therapy with diuretics as well as parenteral feeding failed to relieve symptoms. After a transjugular intrahepatic portosystemic shunt (TIPS) had successfully been placed, pleural effusion decreased considerably. Eight months later, TIPS revision had to be performed because of stenosis, resulting in remission from chylothorax. This case shows that even in the absence of ascites, chylothorax might be caused by portal hypertension and that TIPS can be an effective treatment option.

Entities:  

Keywords:  Chylothorax; Cirrhosis; Liver; Portal hypertension; Transjugular intrahepatic portosystemic shunt

Mesh:

Substances:

Year:  2013        PMID: 23467463      PMCID: PMC3582004          DOI: 10.3748/wjg.v19.i7.1140

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

1.  Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis.

Authors:  Thomas B Kinney; Stephen L Ferrara; Franklin J Miller; Anne C Roberts; Tarek Hassanein
Journal:  J Vasc Interv Radiol       Date:  2004-01       Impact factor: 3.464

2.  Chylothorax.

Authors:  C H Doerr; D L Miller; J H Ryu
Journal:  Semin Respir Crit Care Med       Date:  2001-12       Impact factor: 3.119

Review 3.  Octreotide and chylothorax.

Authors:  Ioannis Kalomenidis
Journal:  Curr Opin Pulm Med       Date:  2006-07       Impact factor: 3.155

4.  TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.

Authors:  Martin Rössle; Alexander L Gerbes
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

Review 5.  Mechanism of sodium retention and ascites formation in cirrhosis.

Authors:  V Arroyo; P Ginès
Journal:  J Hepatol       Date:  1993       Impact factor: 25.083

6.  The lipoprotein profile of chylous and nonchylous pleural effusions.

Authors:  B A Staats; R D Ellefson; L L Budahn; D E Dines; U B Prakash; K Offord
Journal:  Mayo Clin Proc       Date:  1980-11       Impact factor: 7.616

Review 7.  Hepatic hydrothorax: pathophysiology, diagnosis, and management.

Authors:  Nelson Garcia; Anastasios A Mihas
Journal:  J Clin Gastroenterol       Date:  2004-01       Impact factor: 3.062

8.  Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt.

Authors:  Olivier Vignaux; Hervé Gouya; Bertrand Dousset; Elisabeth Mazuir; Catherine Buffet; Yvon Calmus; Paul Legmann
Journal:  J Thorac Imaging       Date:  2002-07       Impact factor: 3.000

Review 9.  Lipid pleural effusions.

Authors:  Vishal Agrawal; Steven A Sahn
Journal:  Am J Med Sci       Date:  2008-01       Impact factor: 2.378

10.  Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics.

Authors:  S Romero; C Martín; L Hernandez; J Verdu; C Trigo; M Perez-Mateo; L Alemany
Journal:  Chest       Date:  1998-07       Impact factor: 9.410

View more
  3 in total

Review 1.  Treatment options in patients with chylothorax.

Authors:  Hans H Schild; Christian P Strassburg; Armin Welz; Jörg Kalff
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

2.  Transudative chylothorax in liver cirrhosis; an underappreciated entity.

Authors:  Asma Migaou; Ahmed Ben Saad; Hassene Baili; Saoussen Cheikh Mhamed; Asma Achour; Wided Bouhlel; Nesrine Fahem; Mabrouk Abdelaaly; Naceur Rouatbi; Samah Joobeur
Journal:  Respir Med Case Rep       Date:  2020-07-10

Review 3.  Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.

Authors:  Sasidharan Rajesh; Tom George; Cyriac Abby Philips; Rizwan Ahamed; Sandeep Kumbar; Narain Mohan; Meera Mohanan; Philip Augustine
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.